Despite several manuscripts offering diagnostic recommendations for MOGAD (18–20) and the International Panel on MOG-Antibody Associated Demyelinating Diseases proposing criteria in 2023 (1), these guidelines do not comprehensively cover all clinical phenotypes associated with MOGAD. The gene discussed is MOG; the disease is demyelinating disease.